Your browser doesn't support javascript.
loading
Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration.
Kambhampati, Siva P; Bhutto, Imran A; Wu, Tony; Ho, Katie; McLeod, D Scott; Lutty, Gerard A; Kannan, Rangaramanujam M.
Afiliación
  • Kambhampati SP; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Bhutto IA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Wu T; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Ho K; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • McLeod DS; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Lutty GA; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America. Electronic address: glutty@jhmi.edu.
  • Kannan RM; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Chemical and Biomolecular Engine
J Control Release ; 335: 527-540, 2021 07 10.
Article en En | MEDLINE | ID: mdl-34058271

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dendrímeros / Degeneración Macular Húmeda / COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dendrímeros / Degeneración Macular Húmeda / COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos